NCT03567980: A trial that was reported late by University of Alabama at Birmingham
This trial has reported, although it was 61 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03567980 |
|---|---|
| Title | A Proof of Concept Clinical Trial Evaluating the Safety and Efficacy of Eucrisa (Crisaborole) in Patients With Seborrheic Dermatitis |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Sept. 1, 2018 |
| Completion date | April 30, 2020 |
| Required reporting date | April 30, 2021, midnight |
| Actual reporting date | June 30, 2021 |
| Date last checked at ClinicalTrials.gov | May 11, 2026 |
| Days late | 61 |